摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-甲基吡啶-2-三氟甲磺酸酯 | 154447-03-7

中文名称
5-甲基吡啶-2-三氟甲磺酸酯
中文别名
——
英文名称
5-methyl-2-(trifluoromethanesulfonyl)oxypyridine
英文别名
5-Methylpyridin-2-YL trifluoromethanesulfonate;(5-methylpyridin-2-yl) trifluoromethanesulfonate
5-甲基吡啶-2-三氟甲磺酸酯化学式
CAS
154447-03-7
化学式
C7H6F3NO3S
mdl
——
分子量
241.191
InChiKey
IULKVMJKTKNACP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    283.0±40.0 °C(Predicted)
  • 密度:
    1.504±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    64.6
  • 氢给体数:
    0
  • 氢受体数:
    7

SDS

SDS:e4799d4e161f45cb459f8a9ab5d2dd82
查看

反应信息

点击查看最新优质反应信息

文献信息

  • A General, Multimetallic Cross-Ullmann Biheteroaryl Synthesis from Heteroaryl Halides and Heteroaryl Triflates
    作者:Kai Kang、Nathan L. Loud、Tarah A. DiBenedetto、Daniel J. Weix
    DOI:10.1021/jacs.1c10907
    日期:2021.12.29
    medicine and materials science, the synthesis of biheteroaryls by cross-coupling remains challenging. We describe here a new, general approach to biheteroaryls: the Ni- and Pd-catalyzed multimetallic cross-Ullmann coupling of heteroaryl halides with triflates. An array of 5-membered, 6-membered, and fused heteroaryl bromides and chlorides, as well as aryl triflates derived from heterocyclic phenols,
    尽管它们对医学和材料科学很重要,但通过交叉偶联合成双杂芳基仍然具有挑战性。我们在这里描述了一种新的、通用的双杂芳基方法:杂芳基卤化物与三氟甲磺酸酯的 Ni 和 Pd 催化的多属交叉 Ullmann 偶联。一系列 5 元、6 元和稠合杂芳基化物和化物,以及衍生自杂环的芳基三氟甲磺酸酯,被证明是该反应中可行的底物(62 个示例,平均产率为 63 ± 17%)。这种方法对双杂芳基的普遍性在 10 μmol 规模的 96 孔板格式中得到进一步证明。一组 96 种可能的产品在一组条件下提供了 >90% 的命中率。此外,可以使用配体、添加剂和还原剂的单个“工具箱板”快速优化低产率组合。
  • Palladium-Catalyzed Cross-Coupling Reaction of Functionalized Aryl- and Hetero­arylbismuthanes with 2-Halo(or 2-Triflyl)­azines and -diazines
    作者:Pauline Petiot、Alexandre Gagnon
    DOI:10.1002/ejoc.201300850
    日期:2013.8
    The palladium-catalyzed cross-coupling of highly functionalized organobismuthanes with 2-halo(or 2-triflyl)pyridines, -pyrimidines, -pyrazines, and -pyridazines is reported. The reaction tolerates numerous functional groups, including aldehydes. The synthesis of a shelf-stable (formylphenyl)bismuth reagent and its use in a cross-coupling reaction is also described.
    催化的高度官能化的有机与 2-卤代(或 2-三甲基)吡啶、-嘧啶、-吡嗪和-哒嗪的交叉偶联被报道。该反应耐受许多官能团,包括醛。还描述了货架稳定(甲酰基苯基)试剂的合成及其在交叉偶联反应中的用途。
  • An efficient preparation of indolizines through a tandem palladium-catalyzed cross-coupling reaction and cycloisomerization
    作者:Hyunseok Kim、Kwangmoo Lee、Sunggak Kim、Phil Ho Lee
    DOI:10.1039/c0cc01945c
    日期:——
    An efficient synthetic method for producing indolizines through a tandem Pd-catalyzed selective allenyl cross-coupling reaction using organoindium reagents and cycloisomerization was developed in a one-pot process.
    一种高效的合成方法通过在一步反应中采用催化的选择性烯丙基交叉偶联反应以及环状异构化,使用有机试剂合成了吲哚啉
  • TRIAZINONE COMPOUND AND T-TYPE CALCIUM CHANNEL INHIBITOR
    申请人:NISSAN CHEMICAL INDUSTRIES, LTD.
    公开号:US20150065705A1
    公开(公告)日:2015-03-05
    There is provided a novel triazinone compound that has an excellent T-type voltage-dependent calcium channel inhibitory activity and is specifically useful for treatment of pain. A compound of Formula (I), a tautomer of the compound, a pharmaceutically acceptable salt thereof, or a solvate thereof: where each substituent is defined in detail in the description or claims, for example R 1 is H or C 1-6 alkoxy, etc., each of L 1 and L 2 is independently a single bond or NR 2 , etc., L 3 is C 1-6 alkylene, etc., A is C 6-14 aryl or 5 to 10-membered heteroaryl which is optionally substituted, etc., B is C 3-11 cycloalkylene, etc., D is C 6-14 aryl or 5 to 10-membered heteroaryl which is optionally substituted, etc.
    提供了一种新型三嗪酮化合物,具有出色的T型电压依赖性钙离子通道抑制活性,并且特别适用于治疗疼痛。化合物式(I)的化合物,其互变异构体,其药学上可接受的盐或其溶剂化物:其中每个取代基在说明或权利要求书中详细定义,例如R1为H或C1-6烷氧基等,每个L1和L2分别独立地为单键或NR2等,L3为C1-6烷基等,A为C6-14芳基或5至10成员杂环芳基,可选地取代等,B为C3-11环烷基等,D为C6-14芳基或5至10成员杂环芳基,可选地取代等。
  • T-TYPE CALCIUM CHANNEL INHIBITOR
    申请人:NISSAN CHEMICAL INDUSTRIES, LTD.
    公开号:US20160237071A1
    公开(公告)日:2016-08-18
    A novel compound that has an excellent T-type calcium channel inhibitory activity and is specifically useful for prevention or treatment of pain, chronic kidney disease and atrial fibrillation. The novel triazinone compound of Formula (I): where each substituent in the formula is defined in detail in the description, and R 1 could be a hydrogen atom, or a C 1-6 alkyl group, etc., E could be a 7 to 14-membered non-aromatic fused heterocyclic group, L 3 could be a C 1-6 alkylene group, etc., D could be a C 6-14 aryl group or a 5 to 10-membered heteroaryl group each of which is optionally substituted, etc., a tautomer of the compound, or a pharmaceutically acceptable salt thereof, or a solvate thereof.
    一种新型化合物,具有出色的T型通道抑制活性,特别适用于预防或治疗疼痛、慢性肾脏疾病和心房颤动。该新型三嗪酮化合物的化学式为(I),其中公式中的每个取代基在描述中都有详细定义,R1可以是氢原子或C1-6烷基等,E可以是7-14个成员的非芳香融合杂环基,L3可以是C1-6亚烷基等,D可以是C6-14芳基或5-10个成员的杂环芳基,每个基团都可以有选择性地取代等,该化合物的互变异构体或药学上可接受的盐或溶剂化物。
查看更多